Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry

Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry

From - Diagnostic Testing & Emerging Technologies
For years it had been hoped that pharmacogenetic (PGx) testing would be a leading application for personalized medicine…


. . . read more

This content is for Paid Members only.
Login Register
New Study Provides Most Comprehensive Overview of  Genetic Test Development, Usage and Spending

New Study Provides Most Comprehensive Overview of Genetic Test Development, Usage and Spending

From - Diagnostic Testing & Emerging Technologies
As might be expected, there has been rapid growth in genetic test availability and spending on these tests since 2014. But, comprehensive new collaborative analysis conducted by…


. . . read more

This content is for Paid Members only.
Login Register